Vanda Atypical Antipsychotic Shows Apparent Genetic Response In Phase III

Study of iloperidone in schizophrenics meets its primary endpoint and also included a genetic profiling evaluation.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet